Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01131065
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients
Conditions: Hepatitis B;   Liver Transplantation
Intervention: Drug: Hepatitis B immune globulin

Study has passed its completion date and status has not been verified in more than two years.